Form 4: Compugen CEO Trades Shares Under 10b5-1 Plan

Compugen Ltd. CEO Ophir Eran executed a Rule 10b5-1 trading plan, acquiring 5,000 ordinary shares and selling 5,000 ordinary shares.

Summary

• Ophir Eran, President and CEO of Compugen Ltd., engaged in stock transactions on April 14, 2026.
• Eran acquired 5,000 ordinary shares at an average price of $0.8292 per share under a Rule 10b5-1 trading plan.
• Concurrently, Eran sold 5,000 ordinary shares at a weighted average price of $2.9042 per share, with individual sales ranging from $2.90 to $2.91.
• Following these transactions, Eran beneficially owns 11,375 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves stock transactions by the CEO, it is executed under a Rule 10b5-1 plan, which is a standard compliance mechanism rather than an indicator of significant company performance or strategic shifts.

Positives

• The CEO is actively managing their stock holdings through a pre-arranged Rule 10b5-1 plan, which can provide a defense against insider trading allegations.
• The acquisition of shares at a lower price point ($0.8292) could indicate a belief in future stock appreciation.
• The sale of shares at a significantly higher price point ($2.9042) demonstrates profitable execution of the trading plan.

Negatives

• The sale of 5,000 shares reduces the CEO's direct beneficial ownership, which could be perceived negatively by some investors if not contextualized by the plan.
• The significant difference between the acquisition price and the sale price might suggest a short-term trading strategy rather than long-term conviction, though this is mitigated by the 10b5-1 plan.

Risks

• The Rule 10b5-1 plan is subject to the reporting person's continued service to the Issuer for the vesting of stock options.
• The weighted average sale price indicates multiple transactions occurred, and the full details of each sale at specific prices are available upon request.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the adoption and execution of a Rule 10b5-1 plan implies a structured approach to managing future stock transactions based on pre-determined criteria.

Management Comments

• The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.
• The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.91 inclusive.
• The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans by executives is a common practice in the biotechnology and technology sectors, like Compugen, to manage personal stock portfolios while adhering to insider trading regulations. This filing indicates standard executive financial planning within the industry.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO might be viewed with caution, but the execution under a Rule 10b5-1 plan mitigates concerns about insider trading. The acquisition at a lower price could be seen as a positive signal.
• Employees: The CEO's continued service is linked to stock option vesting, implying a commitment to the company's operations.
• Management: The filing reflects standard executive financial management practices.

Next Steps

• The reporting person will continue to adhere to the terms of the Rule 10b5-1 trading plan.
• Further transactions under the plan, if any, will be reported on subsequent Form 4 filings.
• The company may provide additional information regarding the sales prices upon request from regulatory bodies or security holders.

Key Dates

Keywords

Compugen Ltd., CGEN, Form 4, Insider Trading, Rule 10b5-1, Ophir Eran, Stock Options, Beneficial Ownership, Securities Transaction